Is Guardant publicly traded?
Table of Contents
Key Data Points Guardant Health operated as a privately held company for roughly six years before listing its shares on the Nasdaq stock exchange in October 2018.
Why is Guardant Health stock dropping?
The continued weakness is ultimately the result of selling after Guardant stock got ahead of itself in the wake of 2020’s COVID-19 pandemic onset.
Is GH a good stock to buy?
The financial health and growth prospects of GH, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this stock lacks momentum and would be a lackluster choice for momentum investors.
Who owns Guardant Health?
In 2012, Eltoukhy and AmirAli Talasaz co-founded Guardant Health, established to “forge a new frontier” in cancer detection and treatment using artificial intelligence and a big data approach.
Who owns Guardant health?
What kind of company is Guardant health?
precision oncology company
About us. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics.
Who are Guardant Health competitors?
Guardant Health’s top competitors include Sophia Genetics, Caris Life Sciences, Castle Biosciences, Biodesix and Tempus. Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.
Is Guardant a good company?
Is Guardant Health a good company to work for? Guardant Health has an overall rating of 3.7 out of 5, based on over 139 reviews left anonymously by employees. 67% of employees would recommend working at Guardant Health to a friend and 60% have a positive outlook for the business.
How many people work at Guardant?
Guardant Health, Inc. has 348 total employees across all of its locations and generates $373.65 million in sales (USD). There are 5 companies in the Guardant Health, Inc….Just $139.99 *
| Year | COST OF REVENUE |
|---|---|
| 2018 | 43.21 |
| 2019 | 70.72 |
| 2020 | 92.53 |
| 2021 | 122.91 |
How many employees does Guardant Health have?
348 total
Guardant Health, Inc. has 348 total employees across all of its locations and generates $373.65 million in sales (USD). There are 5 companies in the Guardant Health, Inc….Just $139.99 *
| Year | Revenue |
|---|---|
| 2019 | 214.38 |
| 2020 | 286.73 |
| 2021 | 373.65 |
Is Guardant Health a good company to work for?
What is Guardant Health’s stock symbol?
Guardant Health trades on the NASDAQ under the ticker symbol “GH.” Who are Guardant Health’s major shareholders? Guardant Health’s stock is owned by a number of institutional and retail investors.
What are Wall Street analysts’price targets for Guardant Health’s stock?
12 Wall Street analysts have issued 1-year price objectives for Guardant Health’s stock. Their forecasts range from $110.00 to $165.00. On average, they anticipate Guardant Health’s share price to reach $138.40 in the next twelve months.
What was the price of the Guardant Health IPO?
(GH) raised $200 million in an initial public offering (IPO) on Thursday, October 4th 2018. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. What is Guardant Health’s stock symbol?
When is Guardant Health’s next earnings release?
View Guardant Health’s Short Interest. When is Guardant Health’s next earnings date? Guardant Health is scheduled to release its next quarterly earnings announcement on Thursday, May 5th 2022. View our earnings forecast for Guardant Health. How were Guardant Health’s earnings last quarter?